Literature DB >> 1280111

Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.

Q Chen1, H Esterbauer, G Jürgens.   

Abstract

Oxidation of human low-density lipoprotein (LDL) was found to be accompanied by the generation of various reactive aldehydes. One of them, 4-hydroxynonenal (HNE), was shown to modify LDL to a form which represents a good model of oxidized LDL (ox-LDL). In order to investigate the epitopes newly formed on HNE-modified LDL, a polyvalent antiserum to HNE-LDL [anti-(HNE-LDL)] was raised in rabbits and the non-specific components were removed with native LDL coupled to CNBr-Sepharose 4B. Competitive fluorescence immunoassay analysis showed that anti-(HNE-LDL) recognized HNE-LDL, copper-oxidized LDL, HNE-albumin and to a lower extent HNE-modified high-density lipoprotein 3 (HNE-HDL3) and ox-HDL3 but not native LDL. A certain degree of cross-reactivity of the antibody with LDLs modified by either hexanal or 2,4-heptadienal was found. No reaction was obtained with LDL labelled with malondialdehyde. From the abilities of HNE-modified poly(L-amino acids) to compete with HNE-LDL for binding to anti-(HNE-LDL), it is postulated that lysine, tyrosine, arginine and histidine are involved in the formation of HNE-derived epitopes on apolipoprotein B (apo B). Using a double-sandwich fluorescence immunoassay [capture antibody: anti-(apo B); detection antibody: anti-(HNE-LDL)] we found that the HNE-derived epitopes were expressed at a far higher degree in ox-LDL and HNE-LDL than in native LDL.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280111      PMCID: PMC1132105          DOI: 10.1042/bj2880249

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

Review 3.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

4.  Detection of malonaldehyde by high-performance liquid chromatography.

Authors:  H Esterbauer; J Lang; S Zadravec; T F Slater
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

5.  Enhanced macrophage degradation of biologically modified low density lipoprotein.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Arteriosclerosis       Date:  1983 Mar-Apr

6.  The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used.

Authors:  T F Slater; B C Sawyer
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

7.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

Authors:  T E Carew; D C Schwenke; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

8.  Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal.

Authors:  G Jürgens; J Lang; H Esterbauer
Journal:  Biochim Biophys Acta       Date:  1986-01-03

9.  Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.

Authors:  J W Heinecke; H Rosen; A Chait
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

10.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis.

Authors:  J T Salonen; S Ylä-Herttuala; R Yamamoto; S Butler; H Korpela; R Salonen; K Nyyssönen; W Palinski; J L Witztum
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

View more
  14 in total

Review 1.  Did the antioxidant trials fail to validate the oxidation hypothesis?

Authors:  S Parthasarathy; N Khan-Merchant; M Penumetcha; B V Khan; N Santanam
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

Review 2.  Urinary biomarkers of oxidative status.

Authors:  Dora Il'yasova; Peter Scarbrough; Ivan Spasojevic
Journal:  Clin Chim Acta       Date:  2012-06-07       Impact factor: 3.786

3.  Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.

Authors:  J Greilberger; G Jürgens
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

4.  Endogenously produced lipoprotein lipase enhances the binding and cell association of native, mildly oxidized and moderately oxidized low-density lipoprotein in mouse peritoneal macrophages.

Authors:  X Wang; J Greilberger; S Levak-Frank; R Zimmermann; R Zechner; G Jürgens
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

5.  Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate.

Authors:  S Toyokuni; K Uchida; K Okamoto; Y Hattori-Nakakuki; H Hiai; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  trans,trans-2,4-decadienal induces mitochondrial dysfunction and oxidative stress.

Authors:  Carlos A O Sigolo; Paolo Di Mascio; Alicia J Kowaltowski; Camila C M Garcia; Marisa H G Medeiros
Journal:  J Bioenerg Biomembr       Date:  2008-03-27       Impact factor: 2.945

7.  Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes.

Authors:  K Uchida; L I Szweda; H Z Chae; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

8.  Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins.

Authors:  M C Slot; R Theunissen; P van Paassen; J G M C Damoiseaux; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2007-05-22       Impact factor: 4.330

Review 9.  The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysis.

Authors:  Corinne M Spickett
Journal:  Redox Biol       Date:  2013-01-21       Impact factor: 11.799

Review 10.  Application of medical and analytical methods in Lyme borreliosis monitoring.

Authors:  Magdalena Ligor; Paweł Olszowy; Bogusław Buszewski
Journal:  Anal Bioanal Chem       Date:  2011-10-21       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.